Menu
Share this

Contact PPD - Investor Relations

Investor Relations
Request For Access To Note Holder Secure Site
Registration Requirements

This form is only for the use by holders of, or prospective investors or market makers in connection with, the (i) 9.375%/10.125% Senior PIK Toggle Notes due 2017 (the "Senior PIK Notes”) issued by Jaguar Holding Company I (“Jaguar I”) or (ii) 9.50% Senior Notes due 2019 (the "Senior Notes") issued by Jaguar Holding Company II (“Jaguar II”) and Pharmaceutical Product Development, LLC (f/k/a Pharmaceutical Product Development, Inc.) (“PPD” and, together with Jaguar I and Jaguar II, the “Issuers”) (The Senior PIK Notes and the Senior Notes are collectively referred to as the “Notes”). Please use this form to request access to the secure website containing confidential information to be provided under the Indenture governing the Notes. If approved, you will be sent a confirmation email to access the secure site.

By requesting access to this information you represent to and covenant with the Issuers that:

1) you (a) are a holder of the Notes, a beneficial owner of the Notes, a prospective investor in the Notes or a market maker and either a "qualified institutional buyer" (QIB) as defined in Rule 144A of the Securities Act of 1933, as amended (the "Securities Act"), or not a "U.S. person" as defined in Rule 902 of the Securities Act; or (b) currently are or intended to be a market maker with respect to the Notes;

2) you will not use the information in violation of applicable securities laws or regulations;

3) you will maintain the strict confidentiality of such information;

4) you will not communicate the information to any other any individual, corporation, partnership, limited liability company, joint venture, association, joint stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other person or entity (each a "Person"); and

5) you are not a Person or an affiliate of a Person that (a) is principally engaged in a similar business as the Issuers or (b) derives a significant portion of its revenues from operating a similar business as the Issuers.

Please provide your information below. Your request will be processed promptly.
*
*
*
*
*
*
*
*
*
*
*
Contact Site Map Legal Notices Privacy Policy

© 2017 Pharmaceutical Product Development, LLC. All rights reserved.

Google+